Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 20:30 UTC |
Stergiou Angelos M.Director · President and CEO
|
GrantCommon Stock | 1,065,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-075773 · tm2618312-1_4seq1.xml · nonDerivative · entry 1 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,759,183 F1 · shares: The Reporting Person received an award of 1,065,000 restricted stock units on June 16, 2026, which shall vest as follows: (i) 25% on December 1, 2026 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 16:43 UTC |
Varian JohnDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-002515 · tm262627-7_4seq1.xml · nonDerivative · entry 1 Varian John · CIK 0001416176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,900 F1 · shares: The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 16:39 UTC |
VAN NOSTRAND ROBERT LDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-002511 · tm262627-6_4seq1.xml · nonDerivative · entry 1 VAN NOSTRAND ROBERT L · CIK 0001225198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,900 F1 · shares: The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 16:38 UTC |
SCHEINBERG DAVID ADirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-002509 · tm262627-5_4seq1.xml · nonDerivative · entry 1 SCHEINBERG DAVID A · CIK 0001250316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,082 F1 · shares: The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:30 UTC |
Wasman JaneDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-002491 · tm262627-1_4seq1.xml · nonDerivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,900 F1 · shares: The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:33 UTC | GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-002502 · tm262627-3_4seq1.xml · nonDerivative · entry 1 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 554,327 F1 · shares: The Reporting Person received an award of 300,000 restricted stock units on January 7, 2026, which shall vest as follows: (i) 25% on December 1, 2026 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
|
| January 07, 2026 Filed Jan 9, 2026 21:35 UTC |
CICIC DRAGANSVP, Chief Development Officer
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-002506 · tm262627-4_4seq1.xml · nonDerivative · entry 1 CICIC DRAGAN · CIK 0001565795 · SVP, Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 557,805 F1 · shares: The Reporting Person received an award of 300,000 restricted stock units on January 7, 2026, which shall vest as follows: (i) 25% on December 1, 2026 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:31 UTC |
Kalin Katherine BachDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-002499 · tm262627-2_4seq1.xml · nonDerivative · entry 1 Kalin Katherine Bach · CIK 0001832671 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,400 F1 · shares: The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 21:07 UTC |
CICIC DRAGANSVP, Chief Development Officer
|
OtherCommon Stock | 63,800 | $1.50 | $95,700.00 |
DisclosureSEC source: 0001104659-25-118882 · tm2532693-3_4seq1.xml · nonDerivative · entry 1 CICIC DRAGAN · CIK 0001565795 · SVP, Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,805 F1 · kind: Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs"). F2 · shares: Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 21:05 UTC | OtherCommon Stock | 58,592 | $1.50 | $87,888.00 |
DisclosureSEC source: 0001104659-25-118878 · tm2532693-2_4seq1.xml · nonDerivative · entry 1 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,327 F1 · kind: Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs"). F2 · shares: Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. Read SEC document |
|
| December 03, 2025 Filed Dec 5, 2025 21:05 UTC |
Stergiou Angelos M.Director · President and CEO
|
OtherCommon Stock | 187,066 | $1.50 | $280,599.00 |
DisclosureSEC source: 0001104659-25-118872 · tm2532693-1_4seq1.xml · nonDerivative · entry 1 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 686,966 F1 · kind: Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs"). F2 · shares: Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 13:45 UTC |
Kalin Katherine BachDirector
|
PurchaseCommon Stock | 63,400 | $1.59 | $100,806.00 |
DisclosureSEC source: 0001104659-25-114806 · tm2531880-1_4seq1.xml · nonDerivative · entry 1 Kalin Katherine Bach · CIK 0001832671 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,400 F1 · price: The price reflects the weighted average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $1.555 to $1.625 per share. Ms. Kalin undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 08:00 UTC |
VAN NOSTRAND ROBERT LDirector
|
PurchaseCommon Stock | 10,000 | $1.48 | $14,800.00 |
DisclosureSEC source: 0001104659-25-059166 · tm2517920-1_4seq1.xml · nonDerivative · entry 1 VAN NOSTRAND ROBERT L · CIK 0001225198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,400 Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 20:42 UTC |
Wasman JaneDirector
|
PurchaseCommon Stock | 20,000 | $1.69 | $33,800.00 |
DisclosureSEC source: 0001104659-25-055495 · tm2516957-1_4seq1.xml · nonDerivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,400 F1 · price: The shares were purchased in multiple transactions at a price of $1.69. The reporting person undertakes to provide SELLAS Life Sciences Group, Inc., any security holder of SELLAS Life Sciences Group, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at the price set forth in this footnote. Read SEC document |
| May 22, 2025 Filed May 22, 2025 20:05 UTC |
Kalin Katherine BachDirector
|
PurchaseCommon Stock | 20,000 | $1.80 | $36,000.00 |
DisclosureSEC source: 0001104659-25-051980 · tm2515989-1_4seq1.xml · nonDerivative · entry 1 Kalin Katherine Bach · CIK 0001832671 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,000 Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 17:30 UTC |
Varian JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001104659-25-003495 · tm253166-2_4seq1.xml · derivative · entry 2 Varian John · CIK 0001416176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2035-01-10 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 17:30 UTC |
Varian JohnDirector
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003495 · tm253166-2_4seq1.xml · nonDerivative · entry 1 Varian John · CIK 0001416176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,900 F1 · shares: The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 17:33 UTC |
VAN NOSTRAND ROBERT LDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001104659-25-003497 · tm253166-4_4seq1.xml · derivative · entry 2 VAN NOSTRAND ROBERT L · CIK 0001225198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2035-01-10 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 17:33 UTC |
VAN NOSTRAND ROBERT LDirector
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003497 · tm253166-4_4seq1.xml · nonDerivative · entry 1 VAN NOSTRAND ROBERT L · CIK 0001225198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,900 F1 · shares: The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 17:34 UTC |
SCHEINBERG DAVID ADirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001104659-25-003499 · tm253166-6_4seq1.xml · derivative · entry 2 SCHEINBERG DAVID A · CIK 0001250316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2035-01-10 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 17:34 UTC |
SCHEINBERG DAVID ADirector
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003499 · tm253166-6_4seq1.xml · nonDerivative · entry 1 SCHEINBERG DAVID A · CIK 0001250316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,082 F1 · shares: The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:33 UTC |
Wasman JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001104659-25-003498 · tm253166-5_4seq1.xml · derivative · entry 2 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2035-01-10 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:33 UTC |
Wasman JaneDirector
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003498 · tm253166-5_4seq1.xml · nonDerivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,900 F1 · shares: The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:34 UTC | GrantStock Option (Right to Buy) · Derivative | 169,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001104659-25-003502 · tm253166-8_4seq1.xml · derivative · entry 3 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,500 Underlying: Common Stock · 169,500 shares Expires 2035-01-10 F3 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 10, 2025 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
|
| January 10, 2025 Filed Jan 14, 2025 22:34 UTC | GrantCommon Stock | 81,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003502 · tm253166-8_4seq1.xml · nonDerivative · entry 2 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,062 F2 · shares: The Reporting Person received an award of 81,300 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
|
| January 10, 2025 Filed Jan 14, 2025 22:34 UTC | GrantCommon Stock | 113,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003502 · tm253166-8_4seq1.xml · nonDerivative · entry 1 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,762 F1 · shares: The Reporting Person received an award of 113,000 restricted stock units on January 10, 2025, which shall vest as follows: (i) 25% on December 1, 2025 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
|
| January 10, 2025 Filed Jan 14, 2025 22:34 UTC |
Stergiou Angelos M.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 385,750 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001104659-25-003501 · tm253166-7_4seq1.xml · derivative · entry 3 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,750 Underlying: Common Stock · 385,750 shares Expires 2035-01-10 F3 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 10, 2025 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:34 UTC |
Stergiou Angelos M.Director · President and CEO
|
GrantCommon Stock | 243,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003501 · tm253166-7_4seq1.xml · nonDerivative · entry 2 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 859,032 F2 · shares: The Reporting Person received an award of 243,900 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:34 UTC |
Stergiou Angelos M.Director · President and CEO
|
GrantCommon Stock | 257,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003501 · tm253166-7_4seq1.xml · nonDerivative · entry 1 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 615,132 F1 · shares: The Reporting Person received an award of 257,000 restricted stock units on January 10, 2025, which shall vest as follows: (i) 25% on December 1, 2025 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:31 UTC |
Kalin Katherine BachDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001104659-25-003496 · tm253166-3_4seq1.xml · derivative · entry 2 Kalin Katherine Bach · CIK 0001832671 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2035-01-10 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:31 UTC |
Kalin Katherine BachDirector
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003496 · tm253166-3_4seq1.xml · nonDerivative · entry 1 Kalin Katherine Bach · CIK 0001832671 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 F1 · shares: The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:30 UTC |
CICIC DRAGANSVP, Chief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 169,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001104659-25-003494 · tm253166-1_4seq1.xml · derivative · entry 3 CICIC DRAGAN · CIK 0001565795 · SVP, Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,500 Underlying: Common Stock · 169,500 shares Expires 2035-01-10 F3 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 10, 2025 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:30 UTC |
CICIC DRAGANSVP, Chief Development Officer
|
GrantCommon Stock | 81,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003494 · tm253166-1_4seq1.xml · nonDerivative · entry 2 CICIC DRAGAN · CIK 0001565795 · SVP, Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,628 F2 · shares: The Reporting Person received an award of 81,300 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:30 UTC |
CICIC DRAGANSVP, Chief Development Officer
|
GrantCommon Stock | 113,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003494 · tm253166-1_4seq1.xml · nonDerivative · entry 1 CICIC DRAGAN · CIK 0001565795 · SVP, Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,328 F1 · shares: The Reporting Person received an award of 113,000 restricted stock units on January 10, 2025, which shall vest as follows: (i) 25% on December 1, 2025 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 22:06 UTC |
CICIC DRAGANSVP, Chief Development Officer
|
OtherCommon Stock | 8,256 | $1.13 | $9,329.28 |
DisclosureSEC source: 0001104659-24-125944 · tm2430303-3_4seq1.xml · nonDerivative · entry 1 CICIC DRAGAN · CIK 0001565795 · SVP, Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,328 F1 · kind: Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs"). F2 · shares: Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 22:05 UTC |
Stergiou Angelos M.Director · President and CEO
|
OtherCommon Stock | 28,289 | $1.13 | $31,966.57 |
DisclosureSEC source: 0001104659-24-125943 · tm2430303-2_4seq1.xml · nonDerivative · entry 1 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 358,132 F1 · kind: Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs"). F2 · shares: Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 22:05 UTC | OtherCommon Stock | 7,165 | $1.13 | $8,096.45 |
DisclosureSEC source: 0001104659-24-125942 · tm2430303-1_4seq1.xml · nonDerivative · entry 1 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,762 F1 · kind: Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs"). F2 · shares: Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. Read SEC document |
|
| January 22, 2024 Filed Jan 25, 2024 06:01 UTC |
Varian JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001104659-24-006392 · tm243935-7_4seq1.xml · derivative · entry 2 Varian John · CIK 0001416176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-01-22 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 06:01 UTC |
Varian JohnDirector
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-006392 · tm243935-7_4seq1.xml · nonDerivative · entry 1 Varian John · CIK 0001416176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,400 F1 · shares: The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 06:03 UTC |
WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001104659-24-006405 · tm243935-9_4seq1.xml · derivative · entry 2 WOOD BARBARA A · CIK 0001220051 · EVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-01-22 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 22, 2024 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 06:03 UTC |
WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-006405 · tm243935-9_4seq1.xml · nonDerivative · entry 1 WOOD BARBARA A · CIK 0001220051 · EVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,225 F1 · shares: The Reporting Person received an award of 35,000 restricted stock units on January 22, 2024, which shall vest as follows: (i) 25% on December 1, 2024 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 06:00 UTC |
VAN NOSTRAND ROBERT LDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001104659-24-006381 · tm243935-6_4seq1.xml · derivative · entry 2 VAN NOSTRAND ROBERT L · CIK 0001225198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-01-22 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 06:00 UTC |
VAN NOSTRAND ROBERT LDirector
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-006381 · tm243935-6_4seq1.xml · nonDerivative · entry 1 VAN NOSTRAND ROBERT L · CIK 0001225198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,400 F1 · shares: The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 06:03 UTC |
SCHEINBERG DAVID ADirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001104659-24-006407 · tm243935-4_4seq1.xml · derivative · entry 2 SCHEINBERG DAVID A · CIK 0001250316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-01-22 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 06:03 UTC |
SCHEINBERG DAVID ADirector
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-006407 · tm243935-4_4seq1.xml · nonDerivative · entry 1 SCHEINBERG DAVID A · CIK 0001250316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,582 F1 · shares: The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 11:02 UTC |
Wasman JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001104659-24-006397 · tm243935-8_4seq1.xml · derivative · entry 2 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-01-22 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 11:02 UTC |
Wasman JaneDirector
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-006397 · tm243935-8_4seq1.xml · nonDerivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,400 F1 · shares: The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 11:04 UTC |
Stergiou Angelos M.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 238,500 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001104659-24-006410 · tm243935-5_4seq1.xml · derivative · entry 2 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,500 Underlying: Common Stock · 238,500 shares Expires 2034-01-22 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 22, 2024 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 11:04 UTC |
Stergiou Angelos M.Director · President and CEO
|
GrantCommon Stock | 159,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-006410 · tm243935-5_4seq1.xml · nonDerivative · entry 1 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 376,421 F1 · shares: The Reporting Person received an award of 159,000 restricted stock units on January 22, 2024, which shall vest as follows: (i) 25% on December 1, 2024 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 11:03 UTC |
Kalin Katherine BachDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001104659-24-006401 · tm243935-3_4seq1.xml · derivative · entry 2 Kalin Katherine Bach · CIK 0001832671 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-01-22 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.